Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Published:2024-02-13 Issue:3 Volume:40 Page:545-553
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Cohen Alexander T.¹^ORCID,Noxon Virginia²^ORCID,Dhamane Amol D.³,Shah Shrushti²,Hines Dionne M.⁴,Alfred Tamuno⁴,Chaves José⁵,Luo Xuemei⁶

Affiliation:

1. Department of Hematological Medicine, Guy’s & St Thomas’ NHS Foundation Trust, King’s College London, London, UK

2. STATinMED, LLC, Dallas, TX, USA

3. Bristol Myers Squibb Company, Lawrenceville, NJ, USA

4. Pfizer Inc, New York, NY, USA

5. Pfizer SLU, Madrid, Spain

6. Pfizer Inc, Groton, CT, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2313092

Reference23 articles.

1. Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial.

2. The Epidemiology of Venous Thromboembolism

3. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study

4. Venous Thromboembolism in Kidney Diseases and Genetic Predisposition

5. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP